“Increasing rates of antibiotic resistance pose a major threat to human health worldwide. The implications for the investment sector are also substantial. Left unchecked, by 2050 drug-resistant infections could be claiming 10 million lives annually and wiping $100 trillion from global GDP.”

This statement by the Farm Animal Investment Risk & Return (FAIRR) Initiative offers a compelling reason to attend their upcoming event on antibiotic resistance and investment risk in New York City on Monday March 20th 2017. The event will be a forum for investors to learn more about the material risks associated with this issue, to explore strategies to identify and manage these risks, and to share investor and company perspectives on opportunities and challenges in addressing resistance.

Cornerstone’s Research team has tackled the topic of antibiotic use in factory farming in the past, and we are pleased to partner with FAIRR in their efforts to educate investors about both the health risks and investment implications of increasing antibiotic resistance. We encourage our clients and industry colleagues to attend. More details below.

Event info, “Superbugs & Super Risks: The Investment Case for Action”

Date:               Monday 20 March 2017,  15:30 -18:00, followed by a drinks reception

Location:    BlackRock, 55 E 52nd St, NYC 10055

Access the event agenda and registration link HERE.

Related Cornerstone Research:

Antibiotics and Animal Health: Value-Chain Implications in the US (October 5, 2015)

Antibiotics and Animal Health: California Raises the Bar (October 13, 2015)

Tracking our Thesis on Nutritional Feed Additives (February 1, 2016)

Cornerstone Contributes to FAIRR’s Investor Case Studies Report (September 28, 2016)

Antibiotics and Animal Health: Recent Data Points Highlight an Accelerating Move (September 26, 2016)

Poultry Antibiotics in Emerging Markets: Should We Rethink Growth? (October 14, 2016)